Nyxoah (NYXH) has released an update.
Nyxoah SA, a medical technology company specializing in the treatment of Obstructive Sleep Apnea, is set to deliver corporate updates at three investor conferences in New York City during September 2024. CEO Olivier Taelman will represent the company at these events, with webcasts available on their Investor Relations website. Additionally, Nyxoah will engage in one-on-one meetings with institutional investors at the conferences.
For further insights into NYXH stock, check out TipRanks’ Stock Analysis page.
